tirzepatide surpass 4 SURPASS-4 trial: slows rate of eGFR decline and reduces UACR in T2DM patients Tirzepatide: First Approval | Drugs

Safety is the biggest concern with compounded versions of semaglutide

Add To Cart Quick View Team Associated Reedy LiPo Pro Starter Box 2100mAh 20C 14.8V Model # ASC27332 $46.99 Coming Soon Add To Cart Quick View Spektrum 7.4V 350mAh 2S 30C LiPo Battery: PH2.0 Model # SPMX-1090 $8.99 In Stock

What was once investigational is now reality

Wegovy is specifically approved for weight loss in people who are overweight or obese, with or without type 2 diabetes

doi:10.1056/NEJMoa1615692 Although not directly focused on semaglutide, this study compared the long-acting insulin analog degludec with glargine in patients with type 2 diabetes and might provide insights into blood pressure effects of different glucose-lowering therapies

Melanie Avalon: Okay, gotcha